Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.958
+0.030 (3.21%)
At close: Dec 20, 2024, 4:00 PM
1.000
+0.042 (4.40%)
After-hours: Dec 20, 2024, 7:15 PM EST
Kronos Bio Market Cap
Kronos Bio has a market cap or net worth of $57.80 million as of December 20, 2024. Its market cap has decreased by -21.96% in one year.
Market Cap
57.80M
Enterprise Value
-41.26M
1-Year Change
-21.96%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on October 9, 2020, Kronos Bio's market cap has decreased from $1.00B to $57.80M, a decrease of -94.23%. That is a compound annual growth rate of -49.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 57.80M | -20.71% |
| Dec 29, 2023 | 72.90M | -20.92% |
| Dec 30, 2022 | 92.18M | -87.96% |
| Dec 31, 2021 | 765.76M | -54.25% |
| Dec 31, 2020 | 1.67B | 67.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 57.13M |
| CareCloud | 56.68M |
| Dyadic International | 56.37M |
| Boundless Bio | 56.19M |
| Repare Therapeutics | 56.11M |
| Connect Biopharma Holdings | 54.84M |
| Elicio Therapeutics | 54.69M |
| Spero Therapeutics | 54.41M |